Lord, Abbett & Co’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.77M | Buy |
+532,350
| New | +$4.77M | 0.02% | 464 |
|
|
2022
Q2 | – | Sell |
-2,318,016
| Closed | -$37.7M | – | 568 |
|
|
2022
Q1 | $37.7M | Buy |
+2,318,016
| New | +$37.7M | 0.1% | 268 |
|
|
2015
Q4 | – | Sell |
-180,413
| Closed | -$2.06M | – | 883 |
|
|
2015
Q3 | $2.06M | Sell |
180,413
-367,266
| -67% | -$4.19M | 0.01% | 844 |
|
|
2015
Q2 | $8.18M | Buy |
+547,679
| New | +$8.18M | 0.02% | 677 |
|